Helmut Prosch
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 9th Edition of the TNM Classification for Lung Cancer.
Huang J, Osarogiagbon R, Giroux D, Nishimura K, Bille A, Cardillo G, Detterbeck F, Kernstine K, Kim H, Lievens Y, Lim E, Marom E, Prosch H, Putora P, Rami-Porta R, Rice D, Rocco G, Rusch V, Schmitt-Opitz I, Vásquez F, van Schil P, Jeffrey Yang C, Asamura H, Members of the Staging and Prognostic Factors Committee, Members of the Advisory Boards, and Participating Institutions of the Lung Cancer Domain. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 9th Edition of the TNM Classification for Lung Cancer. J Thorac Oncol 2023
Oct 20, 2023The IASLC Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 9th Edition of the TNM Classification for Lung Cancer.
Oct 20, 2023J Thorac Oncol 2023
Huang James, Osarogiagbon Raymond U, Giroux Dorothy J, Nishimura Katherine K, Bille Andrea, Cardillo Giuseppe, Detterbeck Frank, Kernstine Kemp, Kim Hong Kwan, Lievens Yolande, Lim Eric, Marom Edith, Prosch Helmut, Putora Paul Martin, Rami-Porta Ramon, Rice David, Rocco Gaetano, Rusch Valerie W, Schmitt-Opitz Isabelle, Vásquez Francisco Suárez, van Schil Paul E, Jeffrey Yang Chi-Fu, Asamura Hisao, Members of the Staging and Prognostic Factors Committee, Members of the Advisory Boards, and Participating Institutions of the Lung Cancer Domain
ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer.
O'Dowd E, Tietzova I, Bartlett E, Devaraj A, Biederer J, Brambilla M, Brunelli A, Chorostowska-Wynimko J, Decaluwe H, Deruysscher D, De Wever W, Donoghue M, Fabre A, Gaga M, van Geffen W, Hardavella G, Kauczor H, Kerpel-Fronius A, van Meerbeeck J, Nagavci B, Nestle U, Novoa N, Prosch H, Prokop M, Putora P, Rawlinson J, Revel M, Snoeckx A, Veronesi G, Vliegenthart R, Weckbach S, Blum T, Baldwin D. ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer. Eur Respir J 2023; 62
Oct 19, 2023ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer.
Oct 19, 2023Eur Respir J 2023; 62
O'Dowd Emma L, Tietzova Ilona, Bartlett Emily, Devaraj Anand, Biederer Jürgen, Brambilla Marco, Brunelli Alessandro, Chorostowska-Wynimko Joanna, Decaluwe Herbert, Deruysscher Dirk, De Wever Walter, Donoghue Matthew, Fabre Aurelie, Gaga Mina, van Geffen Wouter, Hardavella Georgia, Kauczor Hans-Ulrich, Kerpel-Fronius Anna, van Meerbeeck Jan P, Nagavci Blin, Nestle Ursula, Novoa Nuria, Prosch Helmut, Prokop Mathias, Putora Paul Martin, Rawlinson Janette, Revel Marie-Pierre, Snoeckx Annemiek, Veronesi Giulia, Vliegenthart Rozemarijn, Weckbach Sabine, Blum Torsten G, Baldwin David
ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer.
O'Dowd E, Tietzova I, Bartlett E, Devaraj A, Biederer J, Brambilla M, Brunelli A, Chorostowska-Wynimko J, Decaluwe H, Deruysscher D, De Wever W, Donoghue M, Fabre A, Gaga M, van Geffen W, Hardavella G, Kauczor H, Kerpel-Fronius A, van Meerbeeck J, Nagavci B, Nestle U, Novoa N, Prosch H, Prokop M, Putora P, Rawlinson J, Revel M, Snoeckx A, Veronesi G, Vliegenthart R, Weckbach S, Blum T, Baldwin D. ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer. Eur J Cardiothorac Surg 2023; 64
Oct 4, 2023ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer.
Oct 4, 2023Eur J Cardiothorac Surg 2023; 64
O'Dowd Emma L, Tietzova Ilona, Bartlett Emily, Devaraj Anand, Biederer Jürgen, Brambilla Marco, Brunelli Alessandro, Chorostowska-Wynimko Joanna, Decaluwe Herbert, Deruysscher Dirk, De Wever Walter, Donoghue Matthew, Fabre Aurelie, Gaga Mina, van Geffen Wouter, Hardavella Georgia, Kauczor Hans-Ulrich, Kerpel-Fronius Anna, van Meerbeeck Jan P, Nagavci Blin, Nestle Ursula, Novoa Nuria, Prosch Helmut, Prokop Mathias, Putora Paul Martin, Rawlinson Janette, Revel Marie-Pierre, Snoeckx Annemiek, Veronesi Giulia, Vliegenthart Rozemarijn, Weckbach Sabine, Blum Torsten G, Baldwin David
The IASLC Lung Cancer Staging Project: Overview of Challenges and Opportunities in Revising the Nodal Classification of Lung Cancer.
Osarogiagbon R, Van Schil P, Giroux D, Lim E, Putora P, Lievens Y, Cardillo G, Kim H, Rocco G, Bille A, Prosch H, Vásquez F, Nishimura K, Detterbeck F, Rami-Porta R, Rusch V, Asamura H, Huang J. The IASLC Lung Cancer Staging Project: Overview of Challenges and Opportunities in Revising the Nodal Classification of Lung Cancer. J Thorac Oncol 2022
Dec 23, 2022The IASLC Lung Cancer Staging Project: Overview of Challenges and Opportunities in Revising the Nodal Classification of Lung Cancer.
Dec 23, 2022J Thorac Oncol 2022
Osarogiagbon Raymond U, Van Schil Paul, Giroux Dorothy J, Lim Eric, Putora Paul Martin, Lievens Yolande, Cardillo Giuseppe, Kim Hong Kwan, Rocco Gaetano, Bille Andrea, Prosch Helmut, Vásquez Francisco Suárez, Nishimura Katherine K, Detterbeck Frank, Rami-Porta Ramon, Rusch Valerie W, Asamura Hisao, Huang James
Demonstration of CD1a positive cells in the cerebrospinal fluid--A clue to diagnosis of isolated Langerhans cell histiocytosis of the hypothalamic-pituitary axis?
Prosch H, Feldges A, Grois N, Fretz C, Spieler P, Minkov M, Gadner H. Demonstration of CD1a positive cells in the cerebrospinal fluid--A clue to diagnosis of isolated Langerhans cell histiocytosis of the hypothalamic-pituitary axis?. Medical and pediatric oncology 2003; 41:474-6.
Nov 1, 2003Demonstration of CD1a positive cells in the cerebrospinal fluid--A clue to diagnosis of isolated Langerhans cell histiocytosis of the hypothalamic-pituitary axis?
Nov 1, 2003Medical and pediatric oncology 2003; 41:474-6
Prosch Helmut, Feldges Andreas, Grois Nicole, Fretz Christian, Spieler Peter, Minkov Milen, Gadner Helmut